Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
5,078
archived clinical trials in
Major Depression Disorder (MDD)

ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
New York, NY
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
New York, NY
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Rochester, NY
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Durham, NC
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Beachwood, OH
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Beachwood, OH
Click here to add this to my saved trials
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Canton, OH
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Canton, OH
Click here to add this to my saved trials
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Cincinnati, OH
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Cincinnati, OH
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Jenkintown, PA
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Jenkintown, PA
Click here to add this to my saved trials
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Media, PA
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Media, PA
Click here to add this to my saved trials
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Columbia, SC
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Columbia, SC
Click here to add this to my saved trials
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Arlington, TX
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Arlington, TX
Click here to add this to my saved trials
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Houston, TX
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Salt Lake City, UT
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Richmond, VA
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Roanoke, VA
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Roanoke, VA
Click here to add this to my saved trials
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated:  8/1/2016
mi
from
Innsbruck,
ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
A Multi Center, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Investigate the Efficacy and Safety of RO4995819 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder Having Inadequate Response to Ongoing Antidepressant Treatment (ARTDeCo)
Status: Enrolling
Updated: 8/1/2016
mi
from
Innsbruck,
Click here to add this to my saved trials
A Study of the Safety, Tolerability, and Pharmacokinetics of Multiple-Ascending Dose Basimglurant in Healthy Subjects and in Patients With Major Depressive Disorder (MDD)
A Single-Center, Randomized, Investigator/Participant-Blind, Placebo-Controlled, Multiple-Ascending Dose, Semi-Sequential Adaptive Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Basimglurant Following Oral Administration in Healthy Subjects and in Patients With Major Depressive Disorder
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
mi
from
Garden Grove, CA
A Study of the Safety, Tolerability, and Pharmacokinetics of Multiple-Ascending Dose Basimglurant in Healthy Subjects and in Patients With Major Depressive Disorder (MDD)
A Single-Center, Randomized, Investigator/Participant-Blind, Placebo-Controlled, Multiple-Ascending Dose, Semi-Sequential Adaptive Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Basimglurant Following Oral Administration in Healthy Subjects and in Patients With Major Depressive Disorder
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Vortioxetine Versus Placebo in Major Depressive Disorder Comorbid With Social Anxiety Disorder
Status: Enrolling
Updated:  8/23/2016
The Medical Research Network, LLC
mi
from
New York, NY
Vortioxetine Versus Placebo in Major Depressive Disorder Comorbid With Social Anxiety Disorder
Status: Enrolling
Updated: 8/23/2016
The Medical Research Network, LLC
mi
from
New York, NY
Click here to add this to my saved trials
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated:  11/21/2016
Alkermes' Investigational Study Site
mi
from
Tucson, AZ
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated: 11/21/2016
Alkermes' Investigational Study Site
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated:  11/21/2016
Alkermes Investigational Site
mi
from
Fort Myers, FL
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated: 11/21/2016
Alkermes Investigational Site
mi
from
Fort Myers, FL
Click here to add this to my saved trials
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated:  11/21/2016
Alkermes Investigational Site
mi
from
Hoffman Estates, IL
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated: 11/21/2016
Alkermes Investigational Site
mi
from
Hoffman Estates, IL
Click here to add this to my saved trials
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated:  11/21/2016
Alkermes Investigational Site
mi
from
Baltimore, MD
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated: 11/21/2016
Alkermes Investigational Site
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated:  11/21/2016
Alkermes Investigational Site
mi
from
Boston, MA
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated: 11/21/2016
Alkermes Investigational Site
mi
from
Boston, MA
Click here to add this to my saved trials
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated:  11/21/2016
Alkermes Investigational Site
mi
from
New York, NY
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated: 11/21/2016
Alkermes Investigational Site
mi
from
New York, NY
Click here to add this to my saved trials
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated:  11/21/2016
Alkermes Investigational Site
mi
from
Canton, OH
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated: 11/21/2016
Alkermes Investigational Site
mi
from
Canton, OH
Click here to add this to my saved trials
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated:  11/21/2016
Alkermes Investigational Site
mi
from
Oklahoma City, OK
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated: 11/21/2016
Alkermes Investigational Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated:  11/21/2016
Alkermes Study Site
mi
from
Charleston, SC
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated: 11/21/2016
Alkermes Study Site
mi
from
Charleston, SC
Click here to add this to my saved trials
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated:  11/21/2016
Alkermes Investigational Site
mi
from
Bellevue, WA
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated: 11/21/2016
Alkermes Investigational Site
mi
from
Bellevue, WA
Click here to add this to my saved trials
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated:  11/21/2016
Alkermes Investigational Site
mi
from
Oceanside, CA
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated: 11/21/2016
Alkermes Investigational Site
mi
from
Oceanside, CA
Click here to add this to my saved trials
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated:  11/21/2016
Alkermes Investigational Site
mi
from
Santa Ana, CA
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated: 11/21/2016
Alkermes Investigational Site
mi
from
Santa Ana, CA
Click here to add this to my saved trials
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated:  11/21/2016
Alkermes Investigational Site
mi
from
Torrence, CA
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated: 11/21/2016
Alkermes Investigational Site
mi
from
Torrence, CA
Click here to add this to my saved trials
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated:  11/21/2016
Alkermes Investigational Site
mi
from
Lauderhill, FL
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated: 11/21/2016
Alkermes Investigational Site
mi
from
Lauderhill, FL
Click here to add this to my saved trials
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated:  11/21/2016
Alkermes Investigational Site
mi
from
Leesburg, FL
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated: 11/21/2016
Alkermes Investigational Site
mi
from
Leesburg, FL
Click here to add this to my saved trials
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated:  11/21/2016
Alkermes Investigational Site
mi
from
North Miami, FL
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated: 11/21/2016
Alkermes Investigational Site
mi
from
North Miami, FL
Click here to add this to my saved trials
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated:  11/21/2016
Alkermes Investigational Site
mi
from
St. Petersburg, FL
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated: 11/21/2016
Alkermes Investigational Site
mi
from
St. Petersburg, FL
Click here to add this to my saved trials
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated:  11/21/2016
Alkermes Study Site
mi
from
Atlanta, GA
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated: 11/21/2016
Alkermes Study Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated:  11/21/2016
Alkermes Investigational Site
mi
from
Haverhill, MA
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated: 11/21/2016
Alkermes Investigational Site
mi
from
Haverhill, MA
Click here to add this to my saved trials
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated:  11/21/2016
Alkermes Investigational Site
mi
from
Berlin, NJ
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated: 11/21/2016
Alkermes Investigational Site
mi
from
Berlin, NJ
Click here to add this to my saved trials
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated:  11/21/2016
Alkermes Investigational Site
mi
from
Brooklyn, NY
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated: 11/21/2016
Alkermes Investigational Site
mi
from
Brooklyn, NY
Click here to add this to my saved trials
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated:  11/21/2016
Alkermes Investigational Site
mi
from
Dayton, OH
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated: 11/21/2016
Alkermes Investigational Site
mi
from
Dayton, OH
Click here to add this to my saved trials
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated:  11/21/2016
Alkermes Study Site
mi
from
Philadelphia, PA
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated: 11/21/2016
Alkermes Study Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated:  11/21/2016
Alkermes Study Site
mi
from
Austin, TX
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated: 11/21/2016
Alkermes Study Site
mi
from
Austin, TX
Click here to add this to my saved trials
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated:  11/21/2016
Alkermes Investigational Site
mi
from
Dallas, TX
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated: 11/21/2016
Alkermes Investigational Site
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated:  11/21/2016
Alkermes Investigational Site
mi
from
Houston, TX
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated: 11/21/2016
Alkermes Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated:  11/21/2016
Alkermes Investigational Site
mi
from
San Antonio, TX
A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Therapy
Status: Enrolling
Updated: 11/21/2016
Alkermes Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
Effectiveness and Acceptability of MoodGYM in Treating Depressive Symptoms in Chinese Americans
Effectiveness and Acceptability of MoodGYM in Treating Depressive Symptoms in Chinese Americans
Status: Enrolling
Updated:  11/30/2016
Massachusetts General Hospital- Depression Clinical and Research Program
mi
from
Boston, MA
Effectiveness and Acceptability of MoodGYM in Treating Depressive Symptoms in Chinese Americans
Effectiveness and Acceptability of MoodGYM in Treating Depressive Symptoms in Chinese Americans
Status: Enrolling
Updated: 11/30/2016
Massachusetts General Hospital- Depression Clinical and Research Program
mi
from
Boston, MA
Click here to add this to my saved trials
Effectiveness and Acceptability of MoodGYM in Treating Depressive Symptoms in Chinese Americans
Effectiveness and Acceptability of MoodGYM in Treating Depressive Symptoms in Chinese Americans
Status: Enrolling
Updated:  11/30/2016
Ying Wang
mi
from
Beijing,
Effectiveness and Acceptability of MoodGYM in Treating Depressive Symptoms in Chinese Americans
Effectiveness and Acceptability of MoodGYM in Treating Depressive Symptoms in Chinese Americans
Status: Enrolling
Updated: 11/30/2016
Ying Wang
mi
from
Beijing,
Click here to add this to my saved trials
Study to Treat Major Depressive Disorder (MDD) With a New Medication
A Proof-Of-Concept Clinical Trial of a Novel KCNQ Potentiator in Major Depressive Disorder
Status: Enrolling
Updated:  12/20/2016
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Study to Treat Major Depressive Disorder (MDD) With a New Medication
A Proof-Of-Concept Clinical Trial of a Novel KCNQ Potentiator in Major Depressive Disorder
Status: Enrolling
Updated: 12/20/2016
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
Brain Imaging Study in Menopausal Women With and Without Major Depressive Disorder
Measurement of GABA and Neurosteroid Levels in Women With Menopausal Major Depression Before and After Treatment With Estrogen Alone, Fluoxetine Alone, or Estrogen and Fluoxetine and Normal Controls Before and After Treatment With Estrogen
Status: Enrolling
Updated:  12/22/2016
Yale University School of Medicine; Yale Program for Women's Reproductive Behavioral Health
mi
from
New Haven, CT
Brain Imaging Study in Menopausal Women With and Without Major Depressive Disorder
Measurement of GABA and Neurosteroid Levels in Women With Menopausal Major Depression Before and After Treatment With Estrogen Alone, Fluoxetine Alone, or Estrogen and Fluoxetine and Normal Controls Before and After Treatment With Estrogen
Status: Enrolling
Updated: 12/22/2016
Yale University School of Medicine; Yale Program for Women's Reproductive Behavioral Health
mi
from
New Haven, CT
Click here to add this to my saved trials